Table 4 Multivariate analysis to predict myocardial infarction and stroke (Number of antihypertensives as one of the variables)
Variables | OR (95% CI) | P valuea |
|---|---|---|
Myocardial infarction | ||
Age | 1.358 (0.929–1.986) | 0.115 |
African American (vs. other races) | 0.910 (0.416–1.991) | 0.814 |
Body mass index | 0.960 (0.904–1.019) | 0.176 |
Statin use (vs. no use) | 1.269 (0.630–2.557) | 0.504 |
Number of antihypertensives | 2.272 (1.441–3.581) | < 0.001 |
Tight (vs. standard) BP control | 0.788 (0.363–1.707) | 0.545 |
Stroke | ||
Age | 1.792 (1.406–2.284) | < 0.001 |
African American (vs. other races) | 1.059 (0.663–1.690) | 0.812 |
Body mass index | 0.979 (0.944–1.015) | 0.243 |
Statin use (vs. no use) | 1.300 (0.849–1.990) | 0.227 |
Number of antihypertensives | 1.282 (1.011–1.627) | 0.040 |
Tight (vs. standard) BP control | 0.589 (0.377–0.919) | 0.020 |